Carteolol Hydrochloride
Tier C — Watch / tradeCarteolol Hydrochloride
Targets:ADRB2, ADRB1
Brand:Mikelan LA, Mikelan, Arteolol, Carteol, Arteoptic, Teoptic, Cartrol, Ocupress
Indications (approved):Hypertension, Ocular hypertension, Glaucoma, Angina pectoris, Arrhythmia
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Carteolol Hydrochloride-001 | 108-46-3 | Benzene-1,3-diol |
| Carteolol Hydrochloride-002 | 504-02-9 | 1,3-Cyclohexanedione |
| Carteolol Hydrochloride-003 | 5220-49-5 | 3-Aminocyclohex-2-en-1-one |
| Carteolol Hydrochloride-004 | 79-10-7 | 2-Propenoic acid |
| Carteolol Hydrochloride-005 | 5057-12-5 | 1,2,3,4,5,6,7,8-Octahydroquinoline-2,5-dione |
| Carteolol Hydrochloride-006 | 30389-33-4 | 5-Hydroxy-1,2,3,4-tetrahydroquinolin-2-one |
| Code | CAS No. | Intermediate |
|---|---|---|
| Carteolol Hydrochloride-007 | 51781-14-7 | 5-(oxiran-2-ylmethoxy)-1,2,3,4-tetrahydroquinolin-2-one |
| Carteolol Hydrochloride-010 | 51781-13-6 | 5-(3-chloro-2-hydroxypropoxy)-1,2,3,4-tetrahydroquinolin-2-one |
| Carteolol Hydrochloride-008 | 252267-77-9 | decahydroquinoline-2,5-dione |
| Carteolol Hydrochloride-006 | 30389-33-4 | 5-Hydroxy-1,2,3,4-tetrahydroquinolin-2-one |
| Carteolol Hydrochloride-012 | 96-24-2 | (+/-)-2,3-Dihydroxychloropropane |
| Carteolol Hydrochloride-011 | 106-89-8 | (+/-)-2-(Chloromethyl)oxirane |
| Carteolol Hydrochloride-013 | 3132-64-7 | 1-Bromo-2,3-epoxypropane |
| Carteolol Hydrochloride-009 | 75-64-9Available | 1,1-Dimethylethylamine |
| Code | CAS No. | Intermediate |
|---|---|---|
| Carteolol Hydrochloride-014 | 1138-80-3Available | 2-(Benzyloxycarbonylamino)acetic acid |
| Carteolol Hydrochloride-015 | 506-59-2Available | Dimethylamine hydrochloride |
| Carteolol Hydrochloride-016 | 167303-60-8 | Benzyl [2-(dimethylamino)-2-oxoethyl]carbamate |
| Carteolol Hydrochloride-017 | 1857-19-8 | N,N-Dimethylglycinamide |
| Carteolol Hydrochloride-018 | 79-09-4Available | Carboxyethane |
| Carteolol Hydrochloride-019 | 1158271-30-7 | N-[2-(Dimethylamino)-2-oxoethyl]propanamide |
| Carteolol Hydrochloride-020 | 529-28-2 | 1-Iodo-2-methoxybenzene |
| Carteolol Hydrochloride-021 | 1927901-90-3 | N-[2-(Dimethylamino)-2-oxoethyl]-3-(2-methoxyphenyl)propanamide |
| Carteolol Hydrochloride-022 | 1927901-84-5 | 2-(5-Methoxy-2-oxo-3,4-dihydroquinolin-1(2H)-yl)-N,N-dimethylacetamide |
Frequently asked questions
What are the approved indications of Carteolol Hydrochloride?
Approved indications include: Hypertension, Ocular hypertension, Glaucoma, Angina pectoris, Arrhythmia.
When does the Carteolol Hydrochloride patent expire?
No public expiry year is available for Carteolol Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Carteolol Hydrochloride?
3 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Carteolol Hydrochloride intermediates?
4 intermediate CAS of Carteolol Hydrochloride are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Carteolol Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29